Literature DB >> 27098745

Expression Patterns of Organic Anion Transporting Polypeptides 1B1 and 1B3 Protein in Human Pediatric Liver.

Margaret M S Thomson1, Ronald N Hines1, Erin G Schuetz1, Bernd Meibohm2.   

Abstract

Determining appropriate pharmacotherapy in young children can be challenging due to uncertainties in the development of drug disposition pathways. With knowledge of the ontogeny of drug-metabolizing enzymes and an emerging focus on drug transporters, the developmental pattern of the uptake transporters organic anion transporting polypeptide (OATP) 1B1 and 1B3 was assessed by relative protein quantification using Western blotting in 80 human pediatric liver specimens covering an age range from 9 days to 12 years. OATP1B3 exhibited high expression at birth, which declined over the first months of life, and then increased again in the preadolescent period. In comparison with children 6-12 years of age, the relative protein expression of highly glycosylated (total) OATP1B3 was 235% (357%) in children <3 months of age, 33% (64%) in the age group from 3 months to 2 years, and 50% (59%) in children 2-6 years of age. The fraction of highly glycosylated to total OATP1B3 increased with age, indicating ontogenic processes not only at the transcriptional level but also at the post-translational level. Similar to OATP1B3, OATP1B1 showed high interindividual variability in relative protein expression but no statistically significant difference among the studied age groups.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27098745      PMCID: PMC4931892          DOI: 10.1124/dmd.115.069252

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  36 in total

1.  Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8).

Authors:  Katrin Letschert; Dietrich Keppler; Jörg König
Journal:  Pharmacogenetics       Date:  2004-07

Review 2.  Recent secular trends in pubertal timing: implications for evaluation and diagnosis of precocious puberty.

Authors:  Kaspar Sørensen; Annette Mouritsen; Lise Aksglaede; Casper P Hagen; Signe Sloth Mogensen; Anders Juul
Journal:  Horm Res Paediatr       Date:  2012-04-12       Impact factor: 2.852

3.  Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression.

Authors:  Sevasti B Koukouritaki; Pippa Simpson; Catherine K Yeung; Allan E Rettie; Ronald N Hines
Journal:  Pediatr Res       Date:  2002-02       Impact factor: 3.756

4.  Developmental pharmacokinetics.

Authors:  Johannes N van den Anker; Matthias Schwab; Gregory L Kearns
Journal:  Handb Exp Pharmacol       Date:  2011

Review 5.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

6.  Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.

Authors:  Evita van de Steeg; Viktor Stránecký; Hana Hartmannová; Lenka Nosková; Martin Hřebíček; Els Wagenaar; Anita van Esch; Dirk R de Waart; Ronald P J Oude Elferink; Kathryn E Kenworthy; Eva Sticová; Mohammad al-Edreesi; A S Knisely; Stanislav Kmoch; Milan Jirsa; Alfred H Schinkel
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

7.  CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.

Authors:  Martin Wagner; Emina Halilbasic; Hanns-Ulrich Marschall; Gernot Zollner; Peter Fickert; Cord Langner; Kurt Zatloukal; Helmut Denk; Michael Trauner
Journal:  Hepatology       Date:  2005-08       Impact factor: 17.425

8.  Induction of bilirubin clearance by the constitutive androstane receptor (CAR).

Authors:  Wendong Huang; Jun Zhang; Steven S Chua; Mohammed Qatanani; Yunqing Han; Riccarda Granata; David D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

9.  Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters.

Authors:  Miriam G Mooij; Ute I Schwarz; Barbara A E de Koning; J Steven Leeder; Roger Gaedigk; Janneke N Samsom; Edwin Spaans; Johannes B van Goudoever; Dick Tibboel; Richard B Kim; Saskia N de Wildt
Journal:  Drug Metab Dispos       Date:  2014-05-14       Impact factor: 3.922

10.  Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1.

Authors:  Anne T Nies; Mikko Niemi; Oliver Burk; Stefan Winter; Ulrich M Zanger; Bruno Stieger; Matthias Schwab; Elke Schaeffeler
Journal:  Genome Med       Date:  2013-01-11       Impact factor: 11.117

View more
  8 in total

Review 1.  Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.

Authors:  Michael Murray; Fanfan Zhou
Journal:  Br J Pharmacol       Date:  2017-04-24       Impact factor: 8.739

2.  RNA Sequencing Reveals Age and Species Differences of Constitutive Androstane Receptor-Targeted Drug-Processing Genes in the Liver.

Authors:  Sunny Lihua Cheng; Theo K Bammler; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2017-02-23       Impact factor: 3.922

Review 3.  Recent advances in the ontogeny of drug disposition.

Authors:  Brian D Chapron; Alenka Chapron; J Steven Leeder
Journal:  Br J Clin Pharmacol       Date:  2021-04-15       Impact factor: 3.716

Review 4.  Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions.

Authors:  Khondoker Alam; Alexandra Crowe; Xueying Wang; Pengyue Zhang; Kai Ding; Lang Li; Wei Yue
Journal:  Int J Mol Sci       Date:  2018-03-14       Impact factor: 5.923

5.  Alternative Splicing of the SLCO1B1 Gene: An Exploratory Analysis of Isoform Diversity in Pediatric Liver.

Authors:  Bianca D van Groen; Chengpeng Bi; Roger Gaedigk; Vincent S Staggs; Dick Tibboel; Saskia N de Wildt; J Steven Leeder
Journal:  Clin Transl Sci       Date:  2020-01-09       Impact factor: 4.689

Review 6.  Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?

Authors:  Beata Franczyk; Jacek Rysz; Jarosław Miłoński; Tomasz Konecki; Magdalena Rysz-Górzyńska; Anna Gluba-Brzózka
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-13

Review 7.  Innovative approaches and recent advances in the study of ontogeny of drug metabolism and transport.

Authors:  Bianca D van Groen; Karel Allegaert; Dick Tibboel; Saskia N de Wildt
Journal:  Br J Clin Pharmacol       Date:  2020-09-15       Impact factor: 3.716

Review 8.  Pharmacogenetics Approach for the Improvement of COVID-19 Treatment.

Authors:  Ingrid Fricke-Galindo; Ramcés Falfán-Valencia
Journal:  Viruses       Date:  2021-03-05       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.